TTrialPathMatch Me to Trials
← Back to trials
RecruitingInflammatory Bowel Disease (IBD)Ulcerative Colitis (UC)Crohn's Disease

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Eligible age

18–80 yrs

Accepts

All genders

Locations

20 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This is a Phase 2, multicenter, platform study in adult participants with IBD (moderately to severely active Crohn's Disease or Ulcerative Colitis). The primary goal of this study is to assess the safety and efficacy of multiple investigational drugs.

Sponsor: Mirador Therapeutics, Inc.

You may qualify if…

  • ✓ Diagnosis of Crohn's Disease (CD), as confirmed by endoscopy and histopathology
  • ✓ Moderately to severely active CD as defined by Clinical Disease Activity Index (CDAI) and Simple Endoscopic Score (SES-CD)
  • ✓ Meets drug stabilization requirements
  • ✓ Diagnosis of Ulcerative Colitis (UC), as confirmed by endoscopy and histopathology
  • ✓ Moderately to severely active UC as defined by a 3-component MMCS
  • ✓ Meets drug stabilization requirements

You may not qualify if…

  • ✕ Diagnosis of indeterminate colitis
  • ✕ Suspected or diagnosed intra-abdominal or perianal abscess at Screening
  • ✕ Previous small bowel resection with combined resected length of \> 100 cm or previous colonic resection of \> 2 segments
  • ✕ CD isolated to the stomach, duodenum, jejunum, or perianal region, without colonic and/or ileal involvement
  • ✕ Current evidence or within recent history (within last 6 months) of fulminant colitis, toxic megacolon, or bowel perforation
  • ✕ Current stoma or impending need for colostomy or ileostomy
  • ✕ Received IV corticosteroids within 14 days prior to Screening or during the Screening Phase
  • ✕ Previous total proctocolectomy or subtotal colectomy

Where it's recruiting

Alabama

Birmingham

Arizona

Scottsdale · Sun City

Arkansas

Little Rock

Colorado

Colorado Springs · Littleton

Florida

Miami · Orlando · Palmetto Bay · Pensacola

Georgia

Atlanta · Snellville

Illinois

Glenview · Gurnee

Louisiana

Lafayette · Marrero · Shreveport

Michigan

Ypsilanti

Missouri

Bridgeton · Kansas City · Liberty

Nevada

Las Vegas

New York

New York · Rochester

Source: ClinicalTrials.gov · NCT07113522 · last updated 2026-03-12